CollabRx(TM) And Projects In Knowledge(R) Partner To Provide Decision Support Tools To Oncologists

SAN FRANCISCO, March 4, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and Projects In Knowledge, Inc., a leading developer of point-of-care digital and mobile information tools and continuing medical education (CME/CE) programs, today announced a multi-year partnership agreement to jointly distribute informational point-of-care software applications to the more than 35,000 oncologists and other clinicians in the Projects In Knowledge clinician network.

The partnership will focus initially on integrating CollabRx Therapy Finder™ products into the Projects In Knowledge @Point of Care360™ platform. Therapy Finder applications are decision support tools that enable oncologists and pathologists to take into account the genetics of a patient's tumor when determining a treatment plan. The @Point of Care360 platform is a next-generation interactive medical textbook that provides point-of-care accessibility to educational resources and allows clinicians to access a robust and easily searchable knowledge base.

"This partnership with CollabRx and use of its Therapy Finder products, which we believe are 'best of breed', supports our goal to add tools at the point of care that help the clinician in achieving positive patient outcomes," said Robert Stern, CEO of Projects In Knowledge.

CollabRx and Projects In Knowledge will seek support from pharmaceutical and biotechnology companies in the form of educational grants to conduct initial activities of the partnership. Extension of the partnership scope and the development of additional planned extensions of the integrated offering will be commercialized using other mechanisms.

"We are honored to be working with Projects In Knowledge to help oncologists deliver the best possible care to their patients," said Thomas Mika, President & CEO of CollabRx. "This agreement represents a significant milestone by CollabRx in facilitating access to its Therapy Finder product line by large numbers of practicing physicians to inform cancer treatment planning at the point of care."

If you liked this article you might like

3 Stocks Raising The Computer Software & Services Industry Higher

3 Computer Software & Services Stocks Pushing Industry Growth

4 Stocks Under $10 to Trade for Big Breakouts

CollabRx (CLRX) Stock Is Up Today on Medytox Solutions Merger

CollabRx (CLRX) Stock Plummets Today After Pricing Public Offering of Common Stock